USA v. Yu Xue, No. 21-2227 (3d Cir. 2022)Annotate this Case
Defendant, a former scientist employed by GlaxoSmithKline (GSK), pled guilty to a single count of conspiracy to steal trade
secrets, in violation of 18 U.S.C. 1832(a)(5) based on allegations he stole company documents. At sentencing, the government sought a sentencing enhancement based on the “loss” attributable to Defendant's conduct. However, the district court denied the government's request for an enhancement.
On appeal, the Third Circuit affirmed. The court noted that finding that under the commentary to U.S.S.G. 2B1.1, the definition of “loss” includes losses that the defendants intended. However, here, it was uncontested that GSK did not suffer any actual loss. Further, the court determined that the government failed to prove that Defendant purposely sought to inflict pecuniary harm on GSK.